<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26158689</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Disease burden of enterovirus 71 in rural central China: A community-based survey.</ArticleTitle><Pagination><StartPage>2400</StartPage><EndPage>2405</EndPage><MedlinePgn>2400-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2015.1059980</ELocationID><Abstract><AbstractText>In recent years, the epidemics of hand, foot, and mouth disease (HFMD) centered in the Asian-Pacific region have been characterized by high morbidity and mortality. Enterovirus 71 (EV71) infections were responsible for the majority of the infections leading to severe cases of HFMD and death. This is a community-based survey aimed to estimate the disease burden of EV71 in rural central China, especially for HFMD. From 2011 to 2013, demographic and socio-economic data were gathered from 343 ill children and their parents using a structured questionnaire. We quantified the health burden of disease resulting from EV71 infection in disability-adjusted life years (DALYs). Among 343 cases, 303 had confirmed HFMD, 6 presented with herpangina, 25 presented with respiratory symptoms, and 9 presented with non-specific symptoms. The number of severe cases was 47 (including 1 death) and all of these presented with HFMD. The total cost per patient for severe HFMD, mild HFMD, herpangina, respiratory disease, and non-specific disease was $2149.47, $513.22, $53.28, $31.95, and $39.25, respectively. The overall cost of EV71-related diseases as a proportion of local farmers' per capita net income ranged from 0.18% for those with non-specific disease to 187.12% for those with severe HFMD. The loss of DALYs for the 5 forms of disease were 3.47, 1.76, 1.07, 1.44, 1.22 person-years per 1000 persons, respectively. This study provides data on cost of treatment and health burden for diseases caused by EV71, which can be used in the evaluation of EV71 vaccine cost-effectiveness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gan</LastName><ForeName>Zheng-kai</ForeName><Initials>ZK</Initials><AffiliationInfo><Affiliation>a School of Public Health; Southeast University ; Nanjing , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>a School of Public Health; Southeast University ; Nanjing , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing-xin</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>b Jiangsu Provincial Center for Disease Control and Prevention ; Nanjing , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Xue-jun</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>c School of Public Health; Nanjing Medical University ; Nanjing , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>a School of Public Health; Southeast University ; Nanjing , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xue-feng</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>b Jiangsu Provincial Center for Disease Control and Prevention ; Nanjing , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Feng-cai</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>b Jiangsu Provincial Center for Disease Control and Prevention ; Nanjing , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Disability-adjusted life year (DALY)</Keyword><Keyword MajorTopicYN="N">Economic burden</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Health burden</Keyword><Keyword MajorTopicYN="N">foot</Keyword><Keyword MajorTopicYN="N">hand</Keyword><Keyword MajorTopicYN="N">hand, foot and mouth disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>7</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26158689</ArticleId><ArticleId IdType="pmc">PMC4635911</ArticleId><ArticleId IdType="doi">10.1080/21645515.2015.1059980</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Regenmortel MH, Fauquet C, Bishop D, Carstens E, Estes M, Lemon S, et&#xa0;al.. Virus taxonomy: classification and nomenclature of viruses. Seventh report of the International Committee on Taxonomy of Viruses[M]. Academic Press, 2000.</Citation></Reference><Reference><Citation>Alexander JP Jr., Baden L, Pallansch MA, Anderson LJ. Enterovirus 71 infections and neurologic disease&#x2013;United States, 1977-1991. The J Infect Dis 1994; 169:905-8; PMID:8133108; http://dx.doi.org/10.1093/infdis/169.4.905</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/169.4.905</ArticleId><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward JC, Gillespie SM, Kaplan KM, Packer R, Pallansch M, Plotkin S, Schonberger LB. Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr Infect Dis J 1989; 8:611-6; PMID:2797956; http://dx.doi.org/10.1097/00006454-198909000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198909000-00009</ArticleId><ArticleId IdType="pubmed">2797956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennett ML, Birch CJ, Lewis FA, Yung AP, Locarnini SA, Gust ID. Enterovirus type 71 infection in Melbourne. Bull World Health Organ 1974; 51:609-15; PMID:4377551</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2366271</ArticleId><ArticleId IdType="pubmed">4377551</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuda GM, Chang WK, Yeung CY, Tang PS. Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J 1987; 6:206-8; PMID:3562141; http://dx.doi.org/10.1097/00006454-198702000-00013</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198702000-00013</ArticleId><ArticleId IdType="pubmed">3562141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, et&#xa0;al.. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 2010; 7:94; PMID:20459851; http://dx.doi.org/10.1186/1743-422X-7-94</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. The Lancet Infect Dis 2010; 10:778-90; PMID:20961813; http://dx.doi.org/10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LM, Zheng HY, Zheng HZ, Guo X, He JF, Guan DW, Kang M, Liu Z, Ke CW, Li JS, et&#xa0;al.. An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis 2011; 64:13-8; PMID:21266750</Citation><ArticleIdList><ArticleId IdType="pubmed">21266750</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH.. A guide to clinical management and public health response for hand, foot and mouth disease (HFMD)[J]. 2011.</Citation></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, et&#xa0;al.. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis 2014; 14:308-18; PMID:24485991; http://dx.doi.org/10.1016/S1473-3099(13)70342-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert GL, Dickson KE, Waters MJ, Kennett ML, Land SA, Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J 1988; 7:484-8; PMID:2841639; http://dx.doi.org/10.1097/00006454-198807000-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198807000-00007</ArticleId><ArticleId IdType="pubmed">2841639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimaru Y, Nakano S, Yamaoka K, Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Archives of Disease in Childhood 1980; 55:583-8; PMID:6254449; http://dx.doi.org/10.1136/adc.55.8.583</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.55.8.583</ArticleId><ArticleId IdType="pmc">PMC1627055</ArticleId><ArticleId IdType="pubmed">6254449</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJ, Lopez AD. The global burden of disease and injury series, volume 1: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020[J]. Cambridge. MA, 1996.</Citation></Reference><Reference><Citation>Dodhia H, Phillips K. Measuring burden of disease in two inner London boroughs using Disability Adjusted Life Years. J Pub Health 2008; 30:313-21; PMID:18400697; http://dx.doi.org/10.1093/pubmed/fdn015</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdn015</ArticleId><ArticleId IdType="pubmed">18400697</ArticleId></ArticleIdList></Reference><Reference><Citation>Melse JM, Essink-Bot M-L, Kramers P, Hoeymans N. A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Pub Health 2000; 90:1241; PMID:10937004; http://dx.doi.org/10.2105/AJPH.90.8.1241</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.90.8.1241</ArticleId><ArticleId IdType="pmc">PMC1446331</ArticleId><ArticleId IdType="pubmed">10937004</ArticleId></ArticleIdList></Reference><Reference><Citation>Schopper D, Pereira J, Torres A, Cuende N, Alonso M, Baylin A, Ammon C, Rougemont A. Estimating the burden of disease in one Swiss canton: what do disability adjusted life years (DALY) tell us? Int J Epidemiol 2000; 29:871-7; PMID:11034971; http://dx.doi.org/10.1093/ije/29.5.871</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/29.5.871</ArticleId><ArticleId IdType="pubmed">11034971</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray C, Lopez AD. Quantifying disability: data, methods and results. Bull World Health Organ 1994; 72:481; PMID:8062403</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2486704</ArticleId><ArticleId IdType="pubmed">8062403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bureau of Disease Control and Prevention in National Health and Family Planning Commission 
The national epidemic situation of statutory infectious diseases in 2013. http://www.moh.gov.cn/jkj/s3578/201402/26700e8a83c04205913a106545069a11.shtml.</Citation></Reference><Reference><Citation>Zhang Y, Tan X-J, Wang H-Y, Yan D-M, Zhu S-L, Wang D-Y, Ji F, Wang XJ, Gao YJ, Chen L, et&#xa0;al.. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol 2009; 44:262-7; PMID:19269888; http://dx.doi.org/10.1016/j.jcv.2009.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.02.002</ArticleId><ArticleId IdType="pubmed">19269888</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, Sinniah M, Yusof MA, Okuno Y, Okabe N, Shih SR, et&#xa0;al.. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997&#x2013;1998. Jpn J Infect Dis 1999; 52:12-5; PMID:10808253</Citation><ArticleIdList><ArticleId IdType="pubmed">10808253</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhmadishina LV, Eremeeva TP, Trotsenko OE, Ivanova OE, Mikhailov MI, Lukashev AN. Seroepidemiology and molecular epidemiology of enterovirus 71 in Russia. PloS one 2014; 9:e97404; PMID:24819617; http://dx.doi.org/10.1371/journal.pone.0097404</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0097404</ArticleId><ArticleId IdType="pmc">PMC4018281</ArticleId><ArticleId IdType="pubmed">24819617</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F-C, Liang Z-L, Li X-L, Ge H-M, Meng F-Y, Mao Q-Y, Zhang YT, Hu YM, Zhang ZY, Li JX, et&#xa0;al.. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 2013; 381:1037-45; http://dx.doi.org/10.1016/S0140-6736(12)61764-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61764-4</ArticleId><ArticleId IdType="pubmed">23352749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F-C, Meng F-Y, Li J-X, Li X-L, Mao Q-Y, Tao H, Zhang YT, Yao X, Chu K, Chen QH, et&#xa0;al.. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; 381:2024-32; http://dx.doi.org/10.1016/S0140-6736(13)61049-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogilvie I, Khoury H, Goetghebeur MM, El Khoury AC, Giaquinto C. Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infect Dis 2012; 12:62; PMID:22429601; http://dx.doi.org/10.1186/1471-2334-12-62</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-62</ArticleId><ArticleId IdType="pmc">PMC3342230</ArticleId><ArticleId IdType="pubmed">22429601</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekkes M, Theunissen N, Brugman E, Veen S, Verrips E, Koopman H, Vogels T, Wit JM, Verloove-Vanhorick SP. Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1&#x2013;5-year-old children. Quality of Life Research 2000; 9:961-72; PMID:11284215; http://dx.doi.org/10.1023/A:1008981603178</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1008981603178</ArticleId><ArticleId IdType="pubmed">11284215</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunge EM, Essink-Bot ML, Kobussen MP, van Suijlekom-Smit LW, Moll HA, Raat H. Reliability and validity of health status measurement by the TAPQOL. Arch Dis Childhood 2005; 90:351-8; PMID:15781921; http://dx.doi.org/10.1136/adc.2003.048645</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2003.048645</ArticleId><ArticleId IdType="pmc">PMC1720358</ArticleId><ArticleId IdType="pubmed">15781921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CF, Chien LY, Ko YL, Chou YH, Tai CJ, Liou YM. Development and psychometric properties of the Chinese language version of the TAPQOL: a health-related quality of life instrument for preschool children. Int J Nurs Stud 2005; 42:457-65; PMID:15847908; http://dx.doi.org/10.1016/j.ijnurstu.2004.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2004.08.001</ArticleId><ArticleId IdType="pubmed">15847908</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajmil L, Abad S, Sardon O, Morera G, Perez-Yarza EG, Moreno A, Detmar S, Fekkes M, Herdman M, Alonso J. Reliability and validity of the Spanish version of the TAPQOL: a health-related quality of life (HRQOL) instrument for 1- to 5-year-old children. Int J Nurs Stud 2011; 48:549-56; PMID:20951379; http://dx.doi.org/10.1016/j.ijnurstu.2010.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2010.09.004</ArticleId><ArticleId IdType="pubmed">20951379</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et&#xa0;al.. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990&#x2013;2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380:2197-223; http://dx.doi.org/10.1016/S0140-6736(12)61689-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61689-4</ArticleId><ArticleId IdType="pubmed">23245608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudan I, Lawn J, Cousens S, Rowe AK, Boschi-Pinto C, Toma&#x161;kovi&#xe6; L, Mendoza W, Lanata CF, Roca-Feltrer A, Carneiro I, et&#xa0;al.. Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet 2005; 365:2031-40; http://dx.doi.org/10.1016/S0140-6736(05)66697-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)66697-4</ArticleId><ArticleId IdType="pubmed">15950717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BY, Wateska AR, Bailey RR, Tai JH, Bacon KM, Smith KJ. Forecasting the economic value of an Enterovirus 71 (EV71) vaccine. Vaccine 2010; 28:7731-6; PMID:20923711; http://dx.doi.org/10.1016/j.vaccine.2010.09.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.09.065</ArticleId><ArticleId IdType="pmc">PMC2989421</ArticleId><ArticleId IdType="pubmed">20923711</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, et&#xa0;al.. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med 2014; 370:829-37; PMID:24571755; http://dx.doi.org/10.1056/NEJMoa1303224</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, et&#xa0;al.. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014; 370:818-28; PMID:24571754; http://dx.doi.org/10.1056/NEJMoa1304923</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis 2007; 195 Suppl 1:S36-44; PMID:17539193; http://dx.doi.org/10.1086/516716</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/516716</ArticleId><ArticleId IdType="pubmed">17539193</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco LR, Lee LK, Lee VJ, Ooi EE, Shepard DS, Thein TL, Gan V, Cook AR, Lye D, Ng LC, et&#xa0;al.. Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore. PLoS Neglected Tropical Diseases 2011; 5:e1426; PMID:22206028; http://dx.doi.org/10.1371/journal.pntd.0001426</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001426</ArticleId><ArticleId IdType="pmc">PMC3243704</ArticleId><ArticleId IdType="pubmed">22206028</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes[M]. Oxford university press, 2005.</Citation></Reference><Reference><Citation>Kim Y-W, Yoon S-J, Oh I-H. The economic burden of the 2009 pandemic H1N1 influenza in Korea. Scand J Infect Dis 2013; 45:390-6; PMID:23240778; http://dx.doi.org/10.3109/00365548.2012.749423</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2012.749423</ArticleId><ArticleId IdType="pubmed">23240778</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray C, Lopez AD. Global health statistics: a compendium of incidence prevalence and mortality estimates for over 200 conditions. 1996.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>